# Building a Comprehensive Sickle Cell Disease Program in Western Kenya: A Decade of Experience and Growth

**Authors:** Festus Njuguna, Carole Kilach, Cyrus Njuguna, Erick Ayaye, Christopher Wanjiku, Rachael Korir, Consolata Bor, Nancy Midiwo, Everlyne Aliwa, Elvis Oburah, Samuel Mbunya, Joseph Kipkoech, Mary Ann Etling, Tyler Severance, Charles Nathaniel Nessle, Terry Vik, Manjusha Kumar, Chris Roberson, Anne Greist

PMC · DOI: 10.5334/aogh.4725 · Annals of Global Health · 2026-01-20

## TL;DR

This paper describes a decade-long initiative in Kenya to improve sickle cell disease care through training, research, and advocacy.

## Contribution

The paper presents a replicable model for establishing comprehensive sickle cell disease care in resource-limited settings.

## Key findings

- Over 5,000 healthcare workers were trained in sickle cell disease management through various methods.
- Early infant screening and access to medications like hydroxyurea improved clinical outcomes.
- The program's strategies can serve as a template for similar initiatives in resource-limited regions.

## Abstract

Background: Globally, approximately 515,000 infants with Sickle Cell Disease (SCD) are born every year. Approximately 80% of these cases occur in Sub-Saharan Africa (SSA) annually, including 14,000 newborns in Kenya. In SSA, 50%–80% of children will die before the age of 5 years due to a lack of comprehensive SCD care compared to 3% in better-resourced settings.

The Academic Model Providing Access to Healthcare (AMPATH) SCD Program started in 2010 as a partnership between Moi University, Moi Teaching and Referral Hospital (MTRH), and Indiana Hemophilia and Thrombosis Center (IHTC) with a goal to improve access to comprehensive SCD care by increasing capacity through training, clinical care, research, and advocacy.

Findings: The program has trained over 5,000 healthcare workers on different aspects of SCD through face-to-face instruction, virtual training and one-on-one mentorship programs. Early infant screening and support for access to medications like hydroxyurea and antibiotics have been key in improving clinical care. The program has also participated in several research projects and has been a strong advocate for the provision of comprehensive SCD care by the health facilities within the high SCD burden areas in Kenya and the Ministry of Health.

Conclusion: The strategies implemented by the program can serve as a template for establishment of SCD care programs in similar resource-limited settings.

## Linked entities

- **Chemicals:** hydroxyurea (PubChem CID 3657)
- **Diseases:** Sickle Cell Disease (MONDO:0011382)

## Full-text entities

- **Diseases:** SCD (MESH:D000755), Thrombosis (MESH:D013927), Hemophilia (MESH:D006467)
- **Chemicals:** hydroxyurea (MESH:D006918)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829446/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829446/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829446/full.md

---
Source: https://tomesphere.com/paper/PMC12829446